ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy advances presented at the 2026 ASCO Annual Meeting. The conversation explores emerging data for PD-1/VEGF and PD-L1/VEGF bispecific antibodies, the growing role of antibody-drug conjugates in combination with immunotherapy, and promising new strategies targeting KRAS-mutant lung cancers, highlighting how these approaches may reshape the future treatment landscape. Guests: Julie R. Brahmer, MD, MSc, FASCO, FAIO The Marilyn Meyerhoff Professor of Thoracic Oncology Co-Leader, Cancer Immunology Research Program Co-Director, Upper Aerodigestive Cancers Program Director, Johns Hopkins Kimmel Cancer Center, Bayview Campus Professor Solange Peters, MD, PhD Chair of Medical Oncology Director of Oncology Department - CHUV Lausanne University Hospital

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(390)

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted ther...

5 Juni 45min

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the conte...

19 Maj 46min

LCC in Italian: Resectable EGFR-mutant NSCLC

LCC in Italian: Resectable EGFR-mutant NSCLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuse...

8 Maj 49min

AACR 2026 Highlights: KRAS Updates

AACR 2026 Highlights: KRAS Updates

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David...

5 Maj 46min

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussion with Dr. José Corona-Cruz and Dr. Diego Carrillo o...

24 Apr 48min

IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research

IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research

This episode of LCC covers the work of our nursing and allied health professional committee and, most importantly, highlight their role in the care of patients with thoracic malignancies. Guests: ...

21 Apr 48min

IASLC - Lung Cancer Considered India

IASLC - Lung Cancer Considered India

This episode of Lung Cancer Considered covers lung cancer in India and brings awareness about its first and largest advocacy group in the nation. To learn more about Lung Connect India, key members of...

7 Apr 42min

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
medicinvetarna
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
det-morka-psyket
kapitalet-en-podd-om-ekonomi
halsorevolutionen
bildningspodden
rss-vetenskapsradion
sexet
dumforklarat
rss-spraket
vetenskapsradion
rss-vetenskapsradion-2
4health-med-anna-sparre
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
paranormalt-med-caroline-giertz
rss-ronden